Anzeige
Mehr »
Freitag, 11.09.2026 - Börsentäglich über 12.000 News
Positiver Ausblick: "STRONG BUY" für NurExone Biologic!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
10.09.26 | 07:39
1,210 Euro
+0,83 % +0,010
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,1801,21013:53
1,1801,21013:55

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiChina Medical System Holdings Limited: CMS: Initial Prescriptions for Silevimig Injection, the World's First Bispecific Antibody Against Rabies, Issued in China7.093SHENZHEN, Sept 9, 2026 - (ACN Newswire) - On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) ("CMS" or the "Group") is pleased to announce that the initial prescriptions for the Class...
► Artikel lesen
MiChina Medical System Holdings Ltd.: CMS: Initial Prescriptions for Silevimig Injection, the World's First Bispecific Antibody Against Rabies, Issued in China2
04.09.China Medical System Holdings Limited: CMS (867.HK/8A8.SG): Innovative Drug Lumirix(R) Approved in China for Additional Indication of Atopic Dermatitis (AD)513SHENZHEN, CHINA, Sept 4, 2026 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that its subsidiary, Dermavon Holdings Limited ("Dermavon", an innovative...
► Artikel lesen
03.09.China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): Innovative Drug Lumirix Approved in China for Additional Indication of Atopic Dermatitis (AD)232SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that its subsidiary, Dermavon Holdings Limited ("Dermavon",...
► Artikel lesen
03.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR ADDITIONAL INDICATION ATOPIC DERMATITIS (AD) FOR RUXOLITINIB PHOSPHATE ...1
01.09.CMS (00867): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...3
01.09.CMS (00867): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND ...2
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
01.09.CMS (00867): INTERIM REPORT 2026-
28.08.Dividendenbekanntmachungen (28.08.2026)15.441 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  361 DEGREES INTERNATIONAL LTD  KYG884931042  0,222 HKD  0,0243 EUR  ABC-MART INC  JP3152740001  40 JPY  0,2152 EUR  ADMIE IPTO HOLDING...
► Artikel lesen
18.08.CMS (00867): (REVISED) INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20261
17.08.China Medical System Holdings Limited Bottom Line Rises In H12
17.08.CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20261
17.08.CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026-
05.08.CMS (00867): NOTICE OF BOARD MEETING-
15.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR AGE-RELATED MACULAR DEGENERATION INDICATION OF SELF-DEVELOPED ...-
29.06.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION-
29.06.CMS (00867): APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR1
22.06.China Medical System Holdings Limited: CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies443SHENZHEN, June 22, 2026 - (ACN Newswire) - China Medical System Holdings Limited (867.HK/8A8.SG) ("CMS", or the "Group") is pleased to announce that, the New Drug Application for Silevimig Injection...
► Artikel lesen
22.06.China Medical System Holdings Ltd.: CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies245SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (867.HK/8A8.SG) ("CMS", or the "Group") is pleased to announce that, the New Drug Application for Silevimig...
► Artikel lesen
22.06.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION OF CLASS 1 INNOVATIVE DRUG RECOMBINANT FULLY HUMAN BISPECIFIC ANTIBODY AGAINST ...2
Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1